House Bill Seeks To Restore 50% Orphan Drug Tax Credit
A bill recently introduced in the U.S. House of Representatives would increase a tax credit for pharmaceutical companies developing treatments for rare diseases to 50%, its level before the 2017 federal...To view the full article, register now.
Already a subscriber? Click here to view full article